These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 21044445

  • 1. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R, Burgos-Vargas R.
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [Abstract] [Full Text] [Related]

  • 2. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED, Sönmez HE, Gülhan B, Arıcı ZS, Topaloğlu R, Bilginer Y.
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [Abstract] [Full Text] [Related]

  • 3. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
    Salonen PH, Salonen JH, Säilä H, Helminen M, Linna M, Kauppi MJ.
    Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [Abstract] [Full Text] [Related]

  • 5. Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
    Ruperto N, Lovell DJ, Berman A, Anton J, Viola DO, Lauwerys B, Rama ME, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Ally M, Rubio-Pérez N, Gervais E, Van Zyl R, Wong R, Askelson M, Martini A, Brunner HI, Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO).
    J Rheumatol; 2023 Nov; 50(11):1471-1480. PubMed ID: 37453737
    [Abstract] [Full Text] [Related]

  • 6. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV, Whitworth P, Baildam EM.
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [Abstract] [Full Text] [Related]

  • 7. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH, Bulatović Ćalasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM.
    Pediatr Rheumatol Online J; 2015 Mar; 13():5. PubMed ID: 25745368
    [Abstract] [Full Text] [Related]

  • 8. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
    Polat MC, Çelikel E, Tekin ZE, Kurt T, Kaplan MM, Güngörer V, Tekgöz N, Sezer M, Karagöl C, Coşkun S, Öner N, Sezer S, Acar BÇ.
    Eur J Pediatr; 2024 Jun; 183(6):2725-2731. PubMed ID: 38554171
    [Abstract] [Full Text] [Related]

  • 9. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
    Roszkiewicz J, Smolewska E.
    Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
    [Abstract] [Full Text] [Related]

  • 10. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
    Niehues T, Horneff G, Michels H, Höck MS, Schuchmann L, Working Groups Pediatric Rheumatology Germany (AGKJR), Pediatric Rheumatology Austria.
    Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [Abstract] [Full Text] [Related]

  • 15. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.
    Pediatr Rheumatol Online J; 2017 Feb 06; 15(1):11. PubMed ID: 28166785
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
    Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier G, Verazza S, Giancane G, Consolaro A, Ravelli A.
    Pediatr Rheumatol Online J; 2019 Jul 25; 17(1):50. PubMed ID: 31345226
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.